Vimarsana
Biggest News Aggregation in the World

Six Months Ahead News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Six Months Ahead. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Six Months Ahead Today - Breaking & Trending Today

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -September 20, 2023 at 10:03 am EDT - Vimarsana News

Cardiol Therapeutics : MATERIAL CHANGE REPORT - Form 6-K -September 20, 2023 at 10:03 am EDT

Published: September 20, 2023

MATERIAL CHANGE REPORT - Name and Address of Company Cardiol Therapeutics Inc. 2265 Upper Middle Road East, Suite 602 Oakville, Ontario,...

Source: marketscreener.com
Related Topics:
United StatesChris WaddickAndrew HamerHead Of Research DevelopmentCardiol Therapeutics IncCompany Annual Report On FormEuropean UnionCompany PhaseNational InstrumentDrug AdministrationMiddle Road EastElectronic Document AnalysisNews ReleaseEnroll PatientsFull Patient Enrollment AnticipatedSix Months AheadNorth AmericaLatin AmericaCardiol Therapeutic Chief Medical OfficerInvestigational New Drug ApplicationUnited States FoodCardiol TherapeuticsAnnual Report
Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis - Vimarsana News

Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis

Published: September 19, 2023

Cardiol Therapeutics Inc. , a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart...

Source: marketscreener.com
Related Topics:
United StatesTrevor BurnsAndrew HamerEuropean UnionCompany PhaseHead Of Research DevelopmentDrug AdministrationNewsfile CorpCardiol Therapeutics IncCompany Annual Report On FormRecruitment AcceleratingFull Patient Enrollment AnticipatedSix Months AheadPlacebo Controlled Trial RandomizingNorth AmericaLatin AmericaCardiol Therapeutic Chief Medical OfficerInvestigational New Drug ApplicationUnited States FoodCardiol TherapeuticsAnnual ReportInvestor Relations